SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $62 | -99.9% | 3,688 | -10.0% | 0.00% | 0.0% |
Q3 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $70,000 | +2233.3% | 4,098 | +1889.3% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 206 | -17.6% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 250 | -7.1% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 269 | +31.9% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 204 | +30.8% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 156 | -1.9% | 0.00% | – |
Q3 2019 | $1,000 | -87.5% | 159 | -68.2% | 0.00% | – |
Q3 2018 | $8,000 | +300.0% | 500 | +316.7% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 120 | +7.1% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 112 | +6.7% | 0.00% | – |
Q3 2017 | $2,000 | – | 105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |